Skip to main content
. 2020 Jul 27;146(10):2575–2587. doi: 10.1007/s00432-020-03315-6

Fig. 1.

Fig. 1

Summary of grade 1 or 2 adverse events occurring in > 5% of patients in two or more studies. BSC best supportive care, GI gastrointestinal, REILD radioembolization-induced liver disease, SIRT selective internal radiation therapy. Note: areas of circles represent the proportion of study subjects reporting specific symptoms